Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+T cells to promote antitumor immunity

被引:58
作者
Cillo, Anthony R. [1 ,2 ,6 ]
Cardello, Carly [1 ,2 ]
Shan, Feng [1 ,2 ,3 ]
Karapetyan, Lilit [4 ,7 ]
Kunning, Sheryl [1 ,2 ]
Sander, Cindy [4 ]
Rush, Elizabeth [4 ]
Karunamurthy, Arivarasan [5 ]
Massa, Ryan C. [4 ,8 ]
Rohatgi, Anjali [4 ,9 ]
Workman, Creg J. [1 ,2 ]
Kirkwood, John M. [1 ,2 ,4 ,6 ]
Bruno, Tullia C. [1 ,2 ,6 ]
Vignali, Dario A. A. [1 ,2 ,6 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Tumor Microenvironm Ctr, UPMC Hillman Canc Ctr, Sch Med, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Integrat Syst Biol ISB Grad Program, Sch Med, Pittsburgh, PA USA
[4] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA
[5] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
[6] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[8] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA USA
[9] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO USA
关键词
CD8(+) T-CELLS; ANTI-PD-1; THERAPY; SIGNATURES; NIVOLUMAB; INFERENCE; RATIO; CD28;
D O I
10.1016/j.cell.2024.06.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Relatlimab (rela; anti-LAG-3) plus nivolumab (nivo; anti-PD-1) is safe and effective for treatment of advanced melanoma. We designed a trial (NCT03743766) where advanced melanoma patients received rela, nivo, or rela+nivo to interrogate the immunologic mechanisms of rela+nivo. Analysis of biospecimens from this ongoing trial demonstrated that rela+nivo led to enhanced capacity for CD8+ T cell receptor signaling and altered CD8+ T cell differentiation, leading to heightened cytotoxicity despite the retention of an exhaustion profile. Co-expression of cytotoxic and exhaustion signatures was driven by PRDM1, BATF, ETV7, and TOX. Effector function was upregulated in clonally expanded CD8+ T cells that emerged after rela+nivo. A rela+nivo intratumoral CD8+ T cell signature was associated with a favorable prognosis. This intratumoral rela+nivo signature was validated in peripheral blood as an elevated frequency of CD38+TIM3+CD8+ T cells. Overall, we demonstrated that cytotoxicity can be enhanced despite the retention of exhaustion signatures, which will inform future therapeutic strategies.
引用
收藏
页码:4373 / 4388.e15
页数:32
相关论文
共 81 条
[1]  
Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]
[2]   Neoadjuvant relatlimab and nivolumab in resectable melanoma [J].
Amaria, Rodabe N. ;
Postow, Michael ;
Burton, Elizabeth M. ;
Tezlaff, Michael T. ;
Ross, Merrick, I ;
Torres-Cabala, Carlos ;
Glitza, Isabella C. ;
Duan, Fei ;
Milton, Denai R. ;
Busam, Klaus ;
Simpson, Lauren ;
McQuade, Jennifer L. ;
Wong, Michael K. ;
Gershenwald, Jeffrey E. ;
Lee, Jeffrey E. ;
Goepfert, Ryan P. ;
Keung, Emily Z. ;
Fisher, Sarah B. ;
Betof-Warner, Allison ;
Shoushtari, Alexander N. ;
Callahan, Margaret ;
Coit, Daniel ;
Bartlett, Edmund K. ;
Bello, Danielle ;
Momtaz, Parisa ;
Nicholas, Courtney ;
Gu, Aidi ;
Zhang, Xuejun ;
Korivi, Brinda Rao ;
Patnana, Madhavi ;
Patel, Sapna P. ;
Diab, Adi ;
Lucci, Anthony ;
Prieto, Victor G. ;
Davies, Michael A. ;
Allison, James P. ;
Sharma, Padmanee ;
Wargo, Jennifer A. ;
Ariyan, Charlotte ;
Tawbi, Hussein A. .
NATURE, 2022, 611 (7934) :155-+
[3]   LAG-3 and PD-1 synergize on CD8+T cells to drive T cell exhaustion and hinder autocrine IFN-y-dependent anti-tumor immunity [J].
Andrews, Lawrence P. ;
Butler, Samuel C. ;
Cui, Jian ;
Cillo, Anthony R. ;
Cardello, Carly ;
Liu, Chang ;
Brunazzi, Erin A. ;
Baessler, Andrew ;
Xie, Bingxian ;
Kunning, Sheryl R. ;
Ngiow, Shin Foong ;
Manne, Sasikanth ;
Huang, Yinghui Jane ;
Sharpe, Arlene H. ;
Delgoffe, Greg M. ;
Wherry, E. John ;
Kirkwood, John M. ;
Bruno, Tulia C. ;
Workman, Creg J. ;
Vignali, Dario A. A. .
CELL, 2024, 187 (16) :4355-4372.e22
[4]   Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy [J].
Andrews, Lawrence P. ;
Cillo, Anthony R. ;
Karapetyan, Lilit ;
Kirkwood, John M. ;
Workman, Creg J. ;
Vignali, Dario A. A. .
CLINICAL CANCER RESEARCH, 2022, 28 (23) :5030-5039
[5]   Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial [J].
Ascierto, Paolo Antonio ;
Lipson, Evan J. ;
Dummer, Reinhard ;
Larkin, James ;
Long, Georgina V. ;
Sanborn, Rachel E. ;
Chiarion-Sileni, Vanna ;
Dreno, Brigitte ;
Dalle, Stephane ;
Schadendorf, Dirk ;
Callahan, Margaret K. ;
Nyakas, Marta ;
Atkinson, Victoria ;
Gomez-Roca, Carlos Alberto ;
Yamazaki, Naoya ;
Tawbi, Hussein A. ;
Sarkis, Naomey ;
Warad, Deepti ;
Dolfi, Sonia ;
Mitra, Priyam ;
Suryawanshi, Satyendra ;
Grob, Jean-Jacques .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) :2724-+
[6]   T Cell Exhaustion [J].
Baessler, Andrew ;
Vignali, Dario A. A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2024, 42 :179-206
[7]   Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms [J].
Beltra, Jean-Christophe ;
Manne, Sasikanth ;
Abdel-Hakeem, Mohamed S. ;
Kurachi, Makoto ;
Giles, Josephine R. ;
Chen, Zeyu ;
Casella, Valentina ;
Ngiow, Shin Foong ;
Khan, Omar ;
Huang, Yinghui Jane ;
Yan, Patrick ;
Nzingha, Kito ;
Xu, Wei ;
Amaravadi, Ravi K. ;
Xu, Xiaowei ;
Karakousis, Giorgos C. ;
Mitchell, Tara C. ;
Schuchter, Lynn M. ;
Huang, Alexander C. ;
Wherry, E. John .
IMMUNITY, 2020, 52 (05) :825-+
[8]   Generalizing RNA velocity to transient cell states through dynamical modeling [J].
Bergen, Volker ;
Lange, Marius ;
Peidli, Stefan ;
Wolf, F. Alexander ;
Theis, Fabian J. .
NATURE BIOTECHNOLOGY, 2020, 38 (12) :1408-1414
[9]   Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection [J].
Blackburn, Shawn D. ;
Shin, Haina ;
Haining, W. Nicholas ;
Zou, Tao ;
Workman, Creg J. ;
Polley, Antonio ;
Betts, Michael R. ;
Freeman, Gordon J. ;
Vignali, Dario A. A. ;
Wherry, E. John .
NATURE IMMUNOLOGY, 2009, 10 (01) :29-37
[10]   Understanding adverse events of immunotherapy: A mechanistic perspective [J].
Burke, Kelly P. ;
Grebinoski, Stephanie ;
Sharpe, Arlene H. ;
Vignali, Dario A. A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (01)